Pharmaceuticals

Novo Nordisk's 'Semaglutide' gains weight against Eli Lilly in battle for market share The Times of India19:10
GT Voice: China's opening-up in services to create global opportunities Global Times16:07
Biotech industry in New Hampshire poised for continued growth in 2026 Valley News14:07
Trump administration's embattled FDA vaccine chief is leaving — again CBS News12:17
International Women’s Day: digital pathology in early drug discovery Drug Target Review09:05
Ireland places an each-way bet on rival weight loss drugs Wegovy and Mounjaro The Irish News06:18
Zello appoints Kevin Bailey as group chief Medical officer Pharmafile09:40

Latest News

In the last 10 minutes

Wegovy Price Drop and the New Economics of Health Law News06:00

In the last half-hour

Lupin slips as Ankleshwar facility gets two observations from USFDA The Business Standard05:44

From endangered plants come whiffs of inspiration The Economic Times05:41

In the last hour

Lotte Biologics seeks global partnerships at DCAT Week The Korea Herald05:37

Unmasking the hyperactive circuitry of early Alzheimer’s News-Medical.Net05:31

Lupin slips as Ankleshwar facility gets two observations from US FDA The Business Standard05:13

In the last 2 hours

Judge Approves Pfizer, SEC Settlement Tied to Insider Trading at Cohen Hedge Fund Insurance Claims Journal05:10

FMCG and pharma emerge as new strongholds for women CEOs The Times of India04:49

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories continues to impress with returns The Economic Times04:38

In the last 4 hours

Eli Lilly Widens Access to Weight-Loss Injectable as Lower-Cost Pill Nears Approval Power Corridor04:02

In the last 6 hours

Sun Pharma, Hindustan Aeronautics top stock picks for today; check targets The Business Standard01:59

Why the Immutep share price is halted today The Motley Fool (Australia)01:43

Turning biotechnology into hope for farmers Bangkok Post01:42

Stocks to Watch today: UltraTech Cement, Dr Reddy's Labs, Tata Power, Gnfc The Business Standard01:39

In the last 8 hours

Broker says this exciting ASX biotech stock could rise almost 50% The Motley Fool (Australia)23:20 8-Mar-26

Buying This 1 Biotech Stock Now Could Help Make You a Multimillionaire Retiree The Motley Fool22:11 8-Mar-26

Yesterday

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? The Motley Fool21:40 8-Mar-26

Don't get ripped off by this smartwatch scam Phone Arena21:17 8-Mar-26

Teva CEO cashes in $30 million in shares in two weeks CTech19:59 8-Mar-26

Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA The Times of India19:50 8-Mar-26

CBER chief Vinay Prasad to leave FDA once again pharmaphorum19:31 8-Mar-26

Novo Nordisk's 'Semaglutide' gains weight against Eli Lilly in battle for market share The Times of India19:10 8-Mar-26

Hll Lifecare to expand Amrit Pharmacies to 550 outlets by 2027 The Times of India18:56 8-Mar-26

Better Weight Loss Stock: Novo Nordisk Vs. Amgen The Motley Fool18:37 8-Mar-26

1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid The Motley Fool17:36 8-Mar-26

The Only Movie That Put Me To Sleep In A Theater Is Now On Netflix Giant Freakin Robot17:05 8-Mar-26

2 No-Brainer Dividend Stocks to Buy in 2026 The Motley Fool16:55 8-Mar-26

Can This AI Stock Bounce Back in 2026? The Motley Fool16:24 8-Mar-26

GT Voice: China's opening-up in services to create global opportunities Global Times16:07 8-Mar-26

Go-ahead for 2,300-home scheme at former GSK London HQ Construction Enquirer15:56 8-Mar-26

Biotech industry in New Hampshire poised for continued growth in 2026 Valley News14:07 8-Mar-26

2 Underrated Weight Loss Stocks to Buy Now The Motley Fool12:10 8-Mar-26

India set to lead global homoeopathy with certified quality frameworks: Experts The Times of India12:03 8-Mar-26

Middle East conflict hits medical tourism, Indian hospitals tap other markets The Times of India11:04 8-Mar-26

International Women’s Day: digital pathology in early drug discovery Drug Target Review09:05 8-Mar-26

Ireland places an each-way bet on rival weight loss drugs Wegovy and Mounjaro The Irish News06:18 8-Mar-26

Cipla recalls over 400 cartons of cancer drug in US: FDA The Times of India05:56 8-Mar-26

In the last 7 days

This Bizarre Motorola Gadget Was Made To Be Swallowed (And The FDA Cleared It) Slashgear19:03 7-Mar-26

Behind the Title: Becoming an Oxford Professor (at NDM), featuring Professor Phaik Yeong Cheah MORU Tropical Health Network18:18 7-Mar-26

Why did HIMS stock rally 40% within hours? Finance in Bold17:22 7-Mar-26

Where Will Eli Lilly Stock Be in 10 Years? The Motley Fool16:40 7-Mar-26

Can This Next-Gen Obesity Drug Save Novo Nordisk? The Motley Fool16:09 7-Mar-26

Benjamín Naishtat’s ‘Glaxo’ – Everything We Know So Far … Ioncinema15:02 7-Mar-26

China approves Sciwind Biosciences' Ecnoglutide injection for chronic weight management BioSpectrum Asia13:51 7-Mar-26

STAT Plus: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month,… STAT13:26 7-Mar-26

This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul. Kaiser Health News13:15 7-Mar-26

Are You Being Misled By GLP-1 Ads? FDA Issues 30 Telehealth Companies Warning Letters The Dallas Express13:01 7-Mar-26

Trump administration's embattled FDA vaccine chief is leaving — again CBS News12:17 7-Mar-26

FDA official overseeing vaccines resigns amidst controversy The Times of India10:27 7-Mar-26

Cancer patient calls for NHS drug use approval BBC09:49 7-Mar-26

Zello Appoints Kevin Bailey as Group Chief Medical Officer Pharmafile09:40 7-Mar-26

Symbiosis appoints Joanne Anderson as Chief Commercial Officer Pharmafile09:40 7-Mar-26

eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer Pharmafile09:40 7-Mar-26

Tigray Issues Emergency Appeal as Health System Faces ‘Operational Collapse’ The Reporter09:00 7-Mar-26

US Pricing ‘Particularly Negative’ for Swiss Unit, Says Roche Bloomberg Law07:13 7-Mar-26

Novo and Hims end feud, will sell obesity drugs together The Hindu Business Line06:48 7-Mar-26

Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks The Motley Fool06:28 7-Mar-26

Engineered lettuce may turn injectable GLP-1 therapies into oral pills News-Medical.Net04:31 7-Mar-26

Iovance Biotherapeutics (IOVA) Stock Rallies on Analyst Upgrades, Amtagvi Momentum International Business Times - AU Edition03:58 7-Mar-26

Day One Biopharmaceuticals (DAWN) Stock Surges 66% on Servier's $2.5 Billion Acquisition Deal International Business Times - AU Edition03:48 7-Mar-26

New two-drug therapy may help people lose weight while protecting muscle Knowridge Science Report00:36 7-Mar-26

New Findings on Wilson’s Disease from Alexion Summarized (Patient Burden in the Treatment of Wilson Disease in the… Insurance News Net23:28 6-Mar-26

Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market? The Motley Fool23:21 6-Mar-26

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions The Motley Fool23:21 6-Mar-26

Finance Watch: Market Struggles On Iran War, Jobs Data, Impacting Biopharma Stocks Scrip Pharma Intelligence23:20 6-Mar-26

Trump administration's embattled FDA vaccine chief is leaving for the second time MailOnline23:13 6-Mar-26

FDA Vaccines Chief Vinay Prasad to Step Down in April NewsMax23:03 6-Mar-26

Servier Adds To Rare Cancers Portfolio With Proposed Day One Buyout Scrip Pharma Intelligence22:18 6-Mar-26

J&J’s Tecvayli/Darzalex Faspro Wins FDA Approval For Second-Line Myeloma Scrip Pharma Intelligence22:18 6-Mar-26

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency STAT22:18 6-Mar-26

Tylenol use in pregnant women visiting ED dropped after Trump’s unfounded autism claim Center for Infectious Disease Research and Policy21:48 6-Mar-26

Sanofi Selling Medley Unit To Brazilian Drug Co. For $500M Law36021:45 6-Mar-26

Lonza hands off capsule business to investment firm Lone Star in $3B deal FiercePharma21:05 6-Mar-26

Black boxes, white coats and red tape: Regulating the use of AI in drug development JD Supra20:46 6-Mar-26

Ozempic, Wegovy & Similar Drugs: What the Lawsuits Are About National Law Review20:41 6-Mar-26

Two Talc Trials Teed Up Against Johnson & Johnson in Washington, Florida Law.com20:17 6-Mar-26

Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for… FiercePharma20:04 6-Mar-26

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know Barchart20:02 6-Mar-26

The 3 Best Stocks to Invest $1,000 in Right Now The Motley Fool19:17 6-Mar-26

Key drug prices may surge on hoarding and higher demand The Economic Times19:13 6-Mar-26

Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley FiercePharma19:03 6-Mar-26

Is there any upside left in DAWN stock as it soars 65%? Invezz18:44 6-Mar-26

Verrica Investors Gain Class Status Over Delayed FDA Approval Bloomberg Law18:38 6-Mar-26

FDA Accepts Dr. Reddy’s Laboratories’ BLA for Abatacept Biosimilar JD Supra18:33 6-Mar-26

Super Bowl, Winter Olympics defined TV drug ad spending in February, led by AbbVie’s Rinvoq FiercePharma18:02 6-Mar-26

As West Asia conflict rages on, India's pharma exports stare at Rs 5K crore potential losses The Times of India17:59 6-Mar-26

Pipeline Watch: Nine Approvals And Fifteen Phase III Readouts Scrip Pharma Intelligence17:22 6-Mar-26

‘The Pink Pill’ Film Hits the Silver Screen Women's Health17:21 6-Mar-26

Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1 FiercePharma17:21 6-Mar-26

Five Facts about the menopause Pharmafile17:06 6-Mar-26

Taiwan earmarks $755M for multi-year drug supply resilience program FiercePharma16:41 6-Mar-26

RFK Jr. Says FDA Will Lift Ban on Peptides Medpage Today16:41 6-Mar-26

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month? Zacks16:38 6-Mar-26

Day One Biopharmaceuticals Agrees To $2.5 Billion Buyout By Servier; Shares Surge RTT News16:36 6-Mar-26

FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD,… FiercePharma16:31 6-Mar-26

Adam's Take STAT16:28 6-Mar-26

The FDA, urged to avoid controversy, creates a new headache with attack against UniQure STAT16:28 6-Mar-26

QURE Stock Crashes 32% in a Week: Here's What You Should Know Zacks16:08 6-Mar-26

Grünenthal licenses exclusive South Korean rights to Qutenza patch to BCWorld Pharm Manufacturing Chemist16:07 6-Mar-26

Councillors Give Go Ahead to GSK House Redevelopment BrentfordTW816:03 6-Mar-26

Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term Zacks15:58 6-Mar-26

Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term Zacks15:48 6-Mar-26

Ozempic Is A Kickstart, Not Magic - Here Is How To Make Weight Loss Stick Science 2.015:35 6-Mar-26

EMA Panel Backs Moderna's Covid-Flu Shot, Sanofi's Sleeping Sickness Drug, Ipsen's Cancer Drug RTT News15:24 6-Mar-26

Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda FiercePharma15:20 6-Mar-26

FDA Announces a Single Pivotal Trial as the New Default Standard for Drug Approval JD Supra15:19 6-Mar-26

Servier snaps up cancer biotech Day One in $2.5bn deal pharmaphorum15:19 6-Mar-26

In therapies PharmaTimes15:18 6-Mar-26

Day One Shares Surge After $2.5B Servier Deal Benzinga15:14 6-Mar-26

FDA’s Enforcement Discretion Over “No Artificial Color” Claims JD Supra15:09 6-Mar-26

Trump’s surgeon general nominee is running the wellness grifter playbook perfectly The Verge15:08 6-Mar-26

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:07 6-Mar-26

Day One Biopharmaceuticals Stock Surges 65% Over Acquisition Deal With Servier RTT News15:07 6-Mar-26

Federal Autism Briefing Linked To Shifts In Acetaminophen And Leucovorin Prescribing, Study Finds Study Finds15:00 6-Mar-26

STAT Plus: Moderna’s reset hinges on oncology STAT14:52 6-Mar-26

view more headlines

9 Mar 06:00

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Pharmaceuticals

Latest News

About our Pharmaceuticals news

UK Top Stories

World Top Stories